Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Corporate Update

22 Apr 2021 07:00

RNS Number : 2772W
Time Finance PLC
22 April 2021
 

22 April 2021

 

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Corporate Update

 

Net Tangible Assets and Net Cash continue to grow. Arrears below pre-pandemic levels and forbearance down 90% from June 2020 peak

 

Time Finance plc, the AIM listed independent specialist finance provider, is pleased to announce the continued strengthening of its balance sheet with increasing Net Tangible Assets ("NTA") and further increases in its cash reserves. Additionally, the Group continues to be supported by its key funding partners, having recently negotiated renewals and funding increases across a number of facilities within its Asset and Loan divisions.

 

Robust Balance Sheet

 

Notwithstanding the wider macroeconomic environment, the Group's NTA continue to increase month on month. At 31 March 2021, unaudited NTA amounted to approximately £28.5m compared to £26.5m at 31 May 2020. Over the same period, the Group's focus on cash generation has continued to have a positive impact on liquidity with cash and cash equivalents of over £6m at 31 March 2021 compared to approximately £1.5m as at 31 May 2020. These healthy cash levels are vital for future lending growth.

 

The Group's lending book remains robust and resilient with pandemic-related forbearance having reduced from over £25m in June 2020 to under £2.5m at 31 March 2021. Most significantly, as at 31 March 2021, total arrears had fallen below the pre-Covid Levels of 28 February 2020 for the first time since the start of the pandemic.

 

Improved Funding Facilities

 

The Group has distinct funding lines for each of its three own-book lending divisions - Asset, Loan and Invoice Finance - and is pleased to report that it continues to enjoy significant support from all of its key funding partners. The Group has recently negotiated renewed and increased Block Discounting facilities for its Asset and Loan divisions totalling approximately £103.5m. These facilities sit alongside the Group's £42m back-to-back facility for the invoice finance division and the £25m medium-term loan note programme which is used primarily in the Loans division.

 

As has always been the case with the Group's asset and loan funding, these renewed borrowing facilities require the Group to fund between 10% and 20% of each deal from its own resources, with the funder providing the balance. The term lengths with funders are largely "matched" with the Group's own-book lending to UK SMEs. As such, the funding amortises over the duration of the lease or loan term, which is typically three years, and is not impacted by interest rate changes. This matching practice and fixed interest rate policy are key elements of the Group's risk management and governance policies.

 

James Roberts, Chief Financial Officer commented:

 

"I am pleased to report the further strengthening of the Group's commercial partnerships with a number of key funders, many of whom have been long-standing supporters of the Group. I believe this support is reflective of the regard the Group is held in by many parties within our industry. We now have sizeable funding facilities with significant headroom in place across all of our lending divisions. This affords both confidence and visibility in our funding capabilities to help achieve steady organic growth over the foreseeable future as we navigate a return to normality.

 

"I am also delighted that the value of deals in arrears is now below the level experienced before the pandemic began back in the first quarter of 2020. This is testament to both the resilience of our lending book and also the hard work and dedication of our credit and collections staff over the past twelve months."

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (as amended), which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018. Upon publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

 

 

Time Finance plc

 

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

 

 

Cenkos Securities plc (NOMAD)

 

Max Hartley / Ben Jeynes (Nomad)

Julian Morse (Sales)

0207 397 8900

 

 

Walbrook PR

0207 933 8780

Paul Vann / Nicholas Johnson

07768 807631

 

paul.vann@walbrookpr.com

 

About Time Finance:

Time Finance's strategy is to focus on providing or arranging the finance UK SMEs require to fund their businesses and arranging vehicle and property-backed finance for consumers. The multi-product range for SMEs includes asset, vehicle, loan and invoice finance facilities. The Group operates a "hybrid" lending and broking model enabling it to optimize business levels through market and economic cycles

 

More information is available on the Company website www.timefinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKBBNPBKKOQB
Date   Source Headline
21st Sep 20217:00 amRNS2021 Final Results
7th Sep 20217:00 amRNSNotice of Final Results and Investor Presentation
16th Jun 20217:00 amRNSYear-end Trading Update
10th Jun 20217:00 amRNSPermanent CEO Appointment & Investor Presentation
4th Jun 202111:30 amRNSHolding(s) in Company
4th Jun 202111:25 amRNSHolding(s) in Company
27th May 20215:29 pmRNSEmployee Benefit Trust Share Purchase
27th May 20217:00 amRNSExercise of Options
21st May 20217:00 amRNSUnapproved Share Option Scheme – Vesting of Awards
6th May 20217:00 amRNSNew Loan Accreditation & Financial Calendar Update
22nd Apr 20217:00 amRNSCorporate Update
9th Apr 20212:58 pmRNSEmployee Benefit Trust Share Purchase
26th Mar 20217:00 amRNSDirectorate Change
3rd Mar 20217:00 amRNSFurther re Directorate Change
19th Feb 202112:04 pmRNSDirectorate Changes
3rd Feb 20217:00 amRNSTechnology Infrastructure Update
19th Jan 20217:00 amRNSInterim Results
12th Jan 20217:00 amRNSHolding in Company
12th Jan 20217:00 amRNSHolding in Company
6th Jan 20217:00 amRNSDirectorate Changes
15th Dec 20205:15 pmRNSTR-1: Holding in Company - CORRECTION
9th Dec 20207:00 amRNSHalf Year Trading Update & Investor Presentation
1st Jun 20103:19 pmRNSResult of EGM
28th May 20107:00 amRNSUpdate
6th May 20108:37 amRNSStrategic Review - update
6th May 20107:01 amRNSNotice of EGM
6th May 20107:00 amRNSAppointment of adviser
4th May 201011:22 amRNSForm 8.3 - Timestrip PLC
4th May 20107:00 amRNSForm 8 (OPD) Timestrip
19th Apr 20107:30 amRNSStrategic Review Update and Suspension
19th Apr 20107:30 amRNSSuspension - Timestrip plc
24th Mar 20109:50 amRNSRule 8.1- (Timestrip)
19th Mar 201012:47 pmRNSStrategic Review - Update
18th Mar 20107:00 amRNSStrategic Review
5th Feb 20109:04 amRNSDirectorate Change
3rd Feb 20104:29 pmRNSAIM Rule 17
1st Feb 20107:00 amRNSContract Win - Toothbrush Order
5th Nov 200912:23 pmRNSUK Packaging Awards
28th Oct 20097:00 amRNSTimestrip IV - First full adoption by NHS Trust
26th Oct 20097:00 amRNSTimestrip Medical - 1st order in North America
14th Sep 20097:01 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNHS trials and appointment of distributor
24th Jul 20092:18 pmRNSResult of AGM
6th Jul 20097:00 amRNSNew distribution agreement
1st Jul 20097:00 amRNSPreliminary findings on Timestrip IV
29th Jun 20091:26 pmRNSNotice of AGM
11th Jun 20097:00 amRNSFinal Results
8th May 20097:00 amRNSIssue of Equity
5th May 20097:00 amRNSLuton & Dunstable Hospital orders TimestripIV
28th Apr 20097:00 amRNSTimestripIV showcased in NHS funded project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.